| ALS | Amyotrophic lateral sclerosis |
| AD | Alzheimer’s disease |
| 5-HT | 5-Hydroxytryptamine; serotonin |
| BBB | Blood-brain barrier |
| BCH | 2-Aminobicyclo heptane-2-carboxylic acid |
| CAT1 | Cationic amino acid transporter 1 |
| CNS | Central nervous system |
| ECF | Extracellular fluid |
| IDO | Indoleamine 2, 3-dioxygenase |
| IF-γ | Interferon-γ |
| LNAA | Large neutral amino acids |
| LAT1 | l-type amino acid transporter 1 |
| MeAIB | α-Methylaminoisobutyric acid |
| NAA | Neutral amino acids |
| NMG | N-methyl d-glucamine |
| ND | Neurodegenerative disease |
| PD | Parkinson’s disease |
| RT-PCR | Real-time polymerase chain reaction |
| TDO | Tryptophan 2, 3-dioxygenase |
| TNF-α | Tumor necrosis factor α |